Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q1 FY23 results · Apr–Jun 2022
Wockhardt reported revenue from operations of ₹595.00 crore (down 30.8% from Q1 FY22) and net loss of ₹75.00 crore for Q1 FY23 (Apr–Jun 2022), on a consolidated basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 595.00 | 859.55 | −30.8% | 655.00 | −9.2% |
| Other income | 57.00 | 1.65 | 35x | 14.00 | +307.1% |
| Total income | 652.00 | 861.20 | −24.3% | 669.00 | −2.5% |
| Profit before tax | (96.00) | (6.00) | Loss widened | (347.00) | Loss narrowed |
| Net profit for the period | (75.00) | (6.58) | Loss widened | (311.00) | Loss narrowed |
| Attributable to shareholders of the company | (67.00) | (12.71) | Loss widened | (258.00) | Loss narrowed |
| EPS, basic (₹) | (4.64) | (1.15) | not comparable | (21.20) | Loss narrowed |
| Net margin (%) | -12.6 | -0.8 | -47.5 |
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 241.00 | 278.95 | −13.6% | 474.00 | −49.2% |
| Other income | 49.00 | 3.15 | 16x | 22.00 | +122.7% |
| Total income | 290.00 | 282.10 | +2.8% | 496.00 | −41.5% |
| Profit before tax | (54.00) | (77.57) | Loss narrowed | 87.00 | Turned loss |
| Net profit for the period | (37.00) | (48.69) | Loss narrowed | 40.00 | Turned loss |
| EPS, basic (₹) | (2.62) | (4.40) | not comparable | 3.24 | Turned loss |
| Net margin (%) | -15.4 | -17.5 | 8.4 |
Consolidated
- Filed with BSE
- 13 Aug 2022, 17:46 IST
- Board meeting
- 12 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Aug 2022, 17:46 IST
- Board meeting
- 12 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE